Artificial Intelligence for Ulinastatin Responder Outcome & Risk Assessment in CPB

NCT07583290 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

10000

Enrollment

OTHER

Sponsor class

Conditions

Cardiac Surgical Procedures
Cardiopulmonary Bypass
Systemic Inflammatory Response Syndrome
Multiple Organ Dysfunction Syndrome
Postoperative Complications

Interventions

DRUG: ulinastatin

Sponsor

Beijing Anzhen Hospital